Treatment for First-Episode Schizophrenia

ClinicalTrials.gov ID: NCT00000374

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00000374. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Preventing Morbidity in First-Episode Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 3-year study will determine if the antipsychotic medications olanzapine (Zyprexa®) and risperidone (Risperdal®) can help patients with first-episode schizophrenia.

Study identification

NCT ID: NCT00000374
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Northwell Health; Other
Enrollment: 125 participants

Conditions and interventions

Conditions

Schizophrenia

Interventions

Olanzapine Drug
Risperidone Drug

Drug

Eligibility (public fields only)

Age range: 16 Years to 40 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 1998 (Type not available)
Primary completion: May 2007 (Actual)
Completion: May 2007 (Actual)
Last update posted: Jan 13, 2012

1998 – 2007

United States locations

U.S. sites: 2
U.S. states: 1
U.S. cities: 2

Facility	City	State	ZIP	Site status
Hillside Hospital	Glen Oaks	New York	11004	—
Bronx-Lebanon Hospital Center	The Bronx	New York	10456	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00000374, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 13, 2012 · Synced Nov 15, 2026